Uji klinis Obesitas di Utah
29 studi untuk Obesitas mencari peserta di lokasi di Utah.
Kota di Utah
Teks studi resmi (Bahasa Inggris)
Partnership to Reduce Obesity in Community Health Center Patients (SMARTLife Utah)
- Huntsman Cancer Institute at the University of Utah, Salt Lake City
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07582016A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- AMR Clinical, Layton
Menerima pesertaFase 3
Usia 8 hingga 18 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07253285A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Ogden Clinic - Canyon View, Ogden
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07783802Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- AMR Clinical, South Jordan
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07837973A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Velocity Clinical Research, Salt Lake City, West Jordan
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06672549Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Boeson Research, Provo
- Velocity Clinical Research - Salt Lake City, West Jordan
Menerima pesertaFase 3
Usia 45 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07037433Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- AMR Clinical, South Jordan
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07353931A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Ogden Clinic - Canyon View, Ogden
- Diabetes & Endocrine Treatment Specialists, Sandy City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07282600A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Salt Lake City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Salt Lake City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Salt Lake City
Menerima pesertaFase 3Sukarelawan sehat diterima
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07654374A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Kalo Clinical Research, West Valley City
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07215559A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Tanner Clinic, Layton
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT06857942Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Salt Lake City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07284875Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Pantheon Clinical Research, Bountiful
- Alliance for Multispecialty Research Layton Research Center, Layton
- Chrysalis Clinical Research, LLC, St. George
Menerima pesertaFase 3
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07684235Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Pleasant View
- Kailera Clinical Site, Salt Lake City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07284901A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
- ICON Early Phase Services, LLC, Salt Lake City
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07654972A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Salt Lake City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT07784725Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Primary Children's Hospital, Salt Lake City
Menerima pesertaFase 2
Usia 7 hingga 25 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT05082519A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Intermountain Medical Center, Murray
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07567001Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Sandy City
- ACCOMPLISH-1 Research Site, St. George
Menerima pesertaFase 3
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07654361Circadian Intervention to Improve Cardiometabolic Health
- College of Health Research Complex--University of Utah, Salt Lake City
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 45 · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT05943626Effect of Sleep Extension on Ceramides in People With Overweight and Obesity
- College of Health Research Complex--University of Utah, Salt Lake City
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 45 · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT06180837Sit Less, Interact and Move More (SLIMM) 2 Study
- University of Utah, Salt Lake City
Menerima pesertaFase 2
Usia 20 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05173714Testing a Tailored Approach to Long-Term Weight Loss Success
- University of Utah, Salt Lake City
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT07577765A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
- University of Utah Pediatric Endocrine Clinic (Part C and Part D), Salt Lake City
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 12 hingga 65 · Semua jenis kelamin · Diperbarui 22 Des 2025 · NCT06239116PreventT2 Together: Examining the Efficacy of Couple-based Lifestyle Intervention to Prevent Type 2 Diabetes
- University of Utah, Salt Lake City
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Mei 2025 · NCT06690788The Acute T-Rex (Timing of Resistance Exercise) Study
- University of Utah HPER E Buildling, Salt Lake City
Menerima peserta
Usia 50 hingga 74 · Semua jenis kelamin · Diperbarui 3 Apr 2025 · NCT06366399Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.